Colloidal Aggregation Affects the Efficacy of Anticancer Drugs in Cell Culture
Citations Over TimeTop 10% of 2012 papers
Abstract
Many small molecules, including bioactive molecules and approved drugs, spontaneously form colloidal aggregates in aqueous solution at micromolar concentrations. Though it is widely accepted that aggregation leads to artifacts in screens for ligands of soluble proteins, the effects of colloid formation in cell-based assays have not been studied. Here, seven anticancer drugs and one diagnostic reagent were found to form colloids in both biochemical buffer and in cell culture media. In cell-based assays, the antiproliferative activities of three of the drugs were substantially reduced when in colloidal form as compared to monomeric form; a new formulation method ensured the presence of drug colloids versus drug monomers in solution. We also found that Evans Blue, a dye classically used to measure vascular permeability and to demonstrate the "enhanced permeability and retention (EPR) effect" in solid tumors, forms colloids that adsorb albumin, as opposed to older literature that suggested the reverse.
Related Papers
- → Lipid Based Vesicular Drug Delivery Systems(2014)179 cited
- → Delivering more for less: nanosized, minimal-carrier and pharmacoactive drug delivery systems(2021)87 cited
- → Recent advances in drug delivery systems(1985)82 cited
- → Two Important Polysaccharides as Carriers for Drug Delivery(2015)7 cited
- RESEALED ERYTHROCYTE: A NOVEL DRUG DELIVERY SYSTEM(2012)